Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Immunofluorescence analysis of Tau [Tau-5] was done on 70% confluent log phase SHSY5Y cells. The cells were fixed with 4% paraformaldehyde for 15 minutes, permeabilized with 0.25% Triton™ X-100 for 10 minutes, and blocked with 5% BSA for 1 hour at room temperature. The cells were labeled with Tau [Tau-5] Mouse Monoclonal Antibody (AHB0042) at 1µg/mL in 1% BSA and incubated for 3 hours at room temperature and then labeled with Alexa Flour 488 Rabbit Anti-Mouse IgG Secondary Antibody (A11059) at a dilution of 1:400 for 30 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with SlowFade Gold Antifade Mountant with DAPI (S36938). F-actin (Panel c: red) was stained with Alexa Fluor 594 Phalloidin (A12381). Panel d is a merged image showing cytoplasmic localization and panel e is a no primary antibody control. The images were captured at 20X magnification.
|Tested species reactivity||Bovine, Human, Mouse, Sheep, Rat|
|Published species reactivity||Rat, Non-human primate, Bovine, Human, Mouse, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Purified bovine microtubule-associated proteins.|
|Storage buffer||PBS, pH 7.4|
|Contains||15mM sodium azide|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:20-1:200|
|Immunoprecipitation (IP)||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 41 publications below|
|Immunohistochemistry (Frozen) (IHC (F))||See 2 publications below|
|Miscellaneous PubMed (MISC)||See 5 publications below|
|Immunoprecipitation (IP)||See 1 publications below|
|Immunohistochemistry (IHC)||See 4 publications below|
|ELISA (ELISA)||See 2 publications below|
|Immunofluorescence (IF)||See 3 publications below|
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N- terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
FRMD4A-cytohesin signaling modulates the cellular release of tau.
AHB0042 was used in immunocytochemistry and western blot to determine modulation of cellular release of tau by FRMD4A-cytohesin signaling
|Yan X,Nykänen NP,Brunello CA,Haapasalo A,Hiltunen M,Uronen RL,Huttunen HJ||Journal of cell science (129:2003)||2016|
|Not Applicable||Not Cited||
Does inactivation of USP14 enhance degradation of proteasomal substrates that are associated with neurodegenerative diseases?
AHB0042 was used in western blot to study enhanced degradation of proteasomal substrates that are associated with neurodegenerative disease and the effect of inactivation of USP14
|Ortuno D,Carlisle HJ,Miller S||F1000Research (5:null)||2016|
The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.
AHB0042 was used in western blot to test if BAG2 mediates the cold-induced accumulation of phosphorylated tau protein.
|de Paula CA,Santiago FE,de Oliveira AS,Oliveira FA,Almeida MC,Carrettiero DC||Cellular and molecular neurobiology (36:593)||2016|
|Not Applicable||Not Cited||
Pulsed electromagnetic fields promote survival and neuronal differentiation of human BM-MSCs.
AHB0042 was used in western blot to investigate survival and neuronal differentiation of human BM-MSCs by pulsed electromagnetic fields
|Urnukhsaikhan E,Cho H,Mishig-Ochir T,Seo YK,Park JK||Life sciences (151:130)||2016|
ß-Secretase 1's Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice.
AHB0042 was used in western blot to study reduction of hyperphosphorilated Tau by beta-secretase 1's targeting implying autophagy actors in 3xTg-AD mice
|Piedrahita D,Castro-Alvarez JF,Boudreau RL,Villegas-Lanau A,Kosik KS,Gallego-Gomez JC,Cardona-Gómez GP||Frontiers in cellular neuroscience (9:null)||2016|
|Not Applicable||1 mg/ml||
Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy.
AHB0042 was used in western blot to characterize chronic traumatic encephalopathy to determine if phosphorylated tau is unique in epileptic brain and chronic traumatic encephalopathy
|Puvenna V,Engeler M,Banjara M,Brennan C,Schreiber P,Dadas A,Bahrami A,Solanki J,Bandyopadhyay A,Morris JK,Bernick C,Ghosh C,Rapp E,Bazarian JJ,Janigro D||Brain research (1630:225)||2016|
The domestic cat as a natural animal model of Alzheimer's disease.
AHB0042 was used in western blot to study Alzheimer's disease by use of a domestic cat animal model
|Chambers JK,Tokuda T,Uchida K,Ishii R,Tatebe H,Takahashi E,Tomiyama T,Une Y,Nakayama H||Acta neuropathologica communications (3:null)||2015|
Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury.
AHB0042 was used in western blot to assess the deletion of Ccr2 and cavity size and tau pathology after mild traumatic brain injury
|Gyoneva S,Kim D,Katsumoto A,Kokiko-Cochran ON,Lamb BT,Ransohoff RM||Journal of neuroinflammation (12:null)||2015|
Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth.
AHB0042 was used in western blot to investigate the role of Apaf1 in axonogenesis
|De Zio D,Molinari F,Rizza S,Gatta L,Ciotti MT,Salvatore AM,Mathiassen SG,Cwetsch AW,Filomeni G,Rosano G,Ferraro E||Cellular and molecular life sciences : CMLS (72:4173)||2015|
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents.
AHB0042 was used in western blot to test the effects of high fat diet using a mouse model of familial Alzheimer disease.
|Petrov D,Pedrós I,Artiach G,Sureda FX,Barroso E,Pallàs M,Casadesús G,Beas-Zarate C,Carro E,Ferrer I,Vazquez-Carrera M,Folch J,Camins A||Biochimica et biophysica acta (1852:1687)||2015|
Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies.
AHB0042 was used in western blot to elucidate how methylene blue inhibits tau aggregation
|Mohideen SS,Yamasaki Y,Omata Y,Tsuda L,Yoshiike Y||Scientific reports (5:null)||2015|
Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.
AHB0042 was used in immunohistochemistry - paraffin section and western blot to evaluate motor function and tau pathology of P301S tau transgenic mice
|Ohia-Nwoko O,Montazari S,Lau YS,Eriksen JL||Molecular neurodegeneration (9:null)||2014|
|Not Applicable||Not Cited||
Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer's mice.
AHB0042 was used in western blot to use triple transgenic Alzhemier's mice to study short- and long-term CDK5 knockdown and prevention of spatial memory dysfunction and tau pathology
|Castro-Alvarez JF,Uribe-Arias SA,Kosik KS,Cardona-Gómez GP||Frontiers in aging neuroscience (6:null)||2014|
Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
AHB0042 was used in western blot to investigate the role of membrane-anchored versus soluble CX3CL1 in regulating the microglia-mediated amelioration of Abeta pathology
|Lee S,Xu G,Jay TR,Bhatta S,Kim KW,Jung S,Landreth GE,Ransohoff RM,Lamb BT||The Journal of neuroscience : the official journal of the Society for Neuroscience (34:12538)||2014|
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
AHB0042 was used in western blot to investigate the abnormalites in hippocampal energy metabolism in the pathogenesis of Alzheimer disease
|Pedrós I,Petrov D,Allgaier M,Sureda F,Barroso E,Beas-Zarate C,Auladell C,Pallàs M,Vázquez-Carrera M,Casadesús G,Folch J,Camins A||Biochimica et biophysica acta (1842:1556)||2014|
Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells.
AHB0042 was used in western blot to study how induction of Calyculin A in N2a cells can attenuate axonal transport impairment and axonopathy by Berberine
|Liu X,Zhou J,Abid MD,Yan H,Huang H,Wan L,Feng Z,Chen J||PloS one (9:null)||2014|
Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus.
AHB0042 was used in western blot to investigate the murine tau isoforms in brain and peripheral organs
|Liu C,Götz J||PloS one (8:null)||2014|
Cellular prion protein modulates ß-amyloid deposition in aged APP/PS1 transgenic mice.
AHB0042 was used in western blot to test if β-amyloid accumulation affects prion infectivity and if different amounts of PrP affect β-amyloid accumulation.
|Ordóñez-Gutiérrez L,Torres JM,Gavín R,Antón M,Arroba-Espinosa AI,Espinosa JC,Vergara C,Del Río JA,Wandosell F||Neurobiology of aging (34:2793)||2013|
Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8.
AHB0042 was used in western blot to elucidate the role of dietary resveratrol in SAMP8 mice.
|Porquet D,Casadesús G,Bayod S,Vicente A,Canudas AM,Vilaplana J,Pelegrí C,Sanfeliu C,Camins A,Pallàs M,del Valle J||Age (Dordrecht, Netherlands) (35:1851)||2013|
|Bovine||Not Cited||The protein phosphatase PP2A/B¿ binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.||Sontag JM,Nunbhakdi-Craig V,White CL,Halpain S,Sontag E||The Journal of biological chemistry (287:14984)||2012|
|Rat||Not Cited||Differing effects of toxicants (methylmercury, inorganic mercury, lead, amyloid ß, and rotenone) on cultured rat cerebrocortical neurons: differential expression of rho proteins associated with neurotoxicity.||Fujimura M,Usuki F||Toxicological sciences : an official journal of the Society of Toxicology (126:506)||2012|
Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-ß prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
AHB0042 was used in western blot to test if neurite retraction in the SH-SY5Y model is associated with changes in other tau hyperphosphorylable residues.
|Maldonado H,Ramírez E,Utreras E,Pando ME,Kettlun AM,Chiong M,Kulkarni AB,Collados L,Puente J,Cartier L,Valenzuela MA||Journal of neuroscience research (89:1489)||2011|
Hyperphosphorylated Tau in an ¿-synuclein-overexpressing transgenic model of Parkinson's disease.
AHB0042 was used in western blot to examine tauopathy in mice that overexpress human alpha-synuclein as a model of Parkinson's disease.
|Haggerty T,Credle J,Rodriguez O,Wills J,Oaks AW,Masliah E,Sidhu A||The European journal of neuroscience (33:1598)||2011|
Tauopathic changes in the striatum of A53T ¿-synuclein mutant mouse model of Parkinson's disease.
AHB0042 was used in western blot to study the tauopathic changes in the striatum of the alpha-synuclein A53T mutant mouse
|Wills J,Credle J,Haggerty T,Lee JH,Oaks AW,Sidhu A||PloS one (6:null)||2011|
Transgenic mouse and cell culture models demonstrate a lack of mechanistic connection between endoplasmic reticulum stress and tau dysfunction.
AHB0042 was used in western blot to elucidate the between tau aggregation and the unfolded protein response in neurodegenerative disorders
|Spatara ML,Robinson AS||Journal of neuroscience research (88:1951)||2010|
|Mouse||Not Cited||Deletion of tau attenuates heat shock-induced injury in cultured cortical neurons.||Miao Y,Chen J,Zhang Q,Sun A||Journal of neuroscience research (88:102)||2010|
Delphinidin ameliorates beta-amyloid-induced neurotoxicity by inhibiting calcium influx and tau hyperphosphorylation.
AHB0042 was used in western blot to assess the neuroprotective effects of delphinidin against Abeta-induced toxicity
|Kim HS,Sul D,Lim JY,Lee D,Joo SS,Hwang KW,Park SY||Bioscience, biotechnology, and biochemistry (73:1685)||2009|
Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation.
AHB0042 was used in western blot to investigate the potential neuroprotective effects of caffeic acid against Abeta-induced toxicity
|Sul D,Kim HS,Lee D,Joo SS,Hwang KW,Park SY||Life sciences (84:257)||2009|
2,3,7,8-TCDD neurotoxicity in neuroblastoma cells is caused by increased oxidative stress, intracellular calcium levels, and tau phosphorylation.
AHB0042 was used in western blot to investigate the neurotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin
|Sul D,Kim HS,Cho EK,Lee M,Kim HS,Jung WW,Hwang KW,Park SY||Toxicology (255:65)||2009|
Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation.
AHB0042 was used in western blot to elucidate the neuroprotective mechanisms by which curcumin protects against Abeta-induced toxicity
|Park SY,Kim HS,Cho EK,Kwon BY,Phark S,Hwang KW,Sul D||Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association (46:2881)||2008|
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
AHB0042 was used in western blot to determine that Abeta deposition or oestrogen deficiency increases PP2A phosphorylation to compromise tau dephosphorylation and cause neurofibrillary tangle formation in Alzheimer's disease
|Liu R,Zhou XW,Tanila H,Bjorkdahl C,Wang JZ,Guan ZZ,Cao Y,Gustafsson JA,Winblad B,Pei JJ||Journal of cellular and molecular medicine (12:241)||2008|
Enhanced activity of hippocampal BACE1 in a mouse model of postmenopausal memory deficits.
AHB0042 was used in western blot to evaluate if OVX/stress affects levels of Alzheimer's disease-related molecules in the mouse hippocampus
|Fukuzaki E,Takuma K,Himeno Y,Yoshida S,Funatsu Y,Kitahara Y,Mizoguchi H,Ibi D,Koike K,Inoue M,Yamada K||Neuroscience letters (433:141)||2008|
Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
AHB0042 was used in western blot to evaluate five glycogen synthase kinase-3beta inhibitors and lithium in lowering phosphorylated tau and glycogen synthase kinase-3beta enzyme activity levels in 12-day old postnatal rats
|Selenica ML,Jensen HS,Larsen AK,Pedersen ML,Helboe L,Leist M,Lotharius J||British journal of pharmacology (152:959)||2007|
Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons.
AHB0042 was used in western blot to test if sex hormones prevent tau cleavage and Abeta toxicity
|Park SY,Tournell C,Sinjoanu RC,Ferreira A||Neuroscience (144:119)||2007|
|Not Applicable||Not Cited||
Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus.
AHB0042 was used in western blot to assess the effects lithium chloride on cold water stress-induced changes in tau phosphorylation in the mouse hippocampus
|Yoshida S,Maeda M,Kaku S,Ikeya H,Yamada K,Nakaike S||Journal of neural transmission (Vienna, Austria : 1996) (113:1803)||2006|
Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
AHB0042 was used in immunohistochemistry - paraffin section and western blot to characterize a new mouse model of Alzheimer's disease
|Schindowski K,Bretteville A,Leroy K,Bégard S,Brion JP,Hamdane M,Buée L||The American journal of pathology (169:599)||2006|
Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS.
AHB0042 was used in western blot to elucidate how the removal of assembled neurofilaments from axons or misaccumulating neurofilaments in motor neuron cell bodies slows disease in a mouse model of amyotrophic lateral sclerosis
|Lobsiger CS,Garcia ML,Ward CM,Cleveland DW||Proceedings of the National Academy of Sciences of the United States of America (102:10351)||2005|
|Human||Not Cited||Defining Cdk5 ligand chemical space with small molecule inhibitors of tau phosphorylation.||Ahn JS,Radhakrishnan ML,Mapelli M,Choi S,Tidor B,Cuny GD,Musacchio A,Yeh LA,Kosik KS||Chemistry and biology (12:811)||2005|
|Human||Not Cited||Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2.||Paganoni S,Ferreira A||Journal of cell science (118:433)||2005|
|Rat||Not Cited||A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.||Zheng YL,Kesavapany S,Gravell M,Hamilton RS,Schubert M,Amin N,Albers W,Grant P,Pant HC||The EMBO journal (24:209)||2005|
|Mouse||Not Cited||Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules.||Takahashi S,Saito T,Hisanaga S,Pant HC,Kulkarni AB||The Journal of biological chemistry (278:10506)||2003|
A Neurogenic Perspective of Sarcopenia: Time Course Study of Sciatic Nerves From Aging Mice.
AHB0042 was used in immunohistochemistry - frozen section and western blot to utilize a time course study of sciatic nerves from aging mice to gain a neurogenic perspective of sarcopenia
|Krishnan VS,White Z,McMahon CD,Hodgetts SI,Fitzgerald M,Shavlakadze T,Harvey AR,Grounds MD||Journal of neuropathology and experimental neurology (75:464)||2016|
Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene.
AHB0042 was used in immunohistochemistry - frozen section and western blot to isolate cis-acting regulatory elements for the generation of transgenic zebrafish models of neurodegeneration
|Bai Q,Garver JA,Hukriede NA,Burton EA||Nucleic acids research (35:6501)||2007|
Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation.
AHB0042 was used in western blot to investigate the role of channel gating in mammalian proteasomes
|Choi WH,de Poot SA,Lee JH,Kim JH,Han DH,Kim YK,Finley D,Lee MJ||Nature communications (7:null)||2016|
Presence of a neo-epitope and absence of amyloid beta and tau protein in degenerative hippocampal granules of aged mice.
AHB0042 was used in immunohistochemistry (frozen) to study the composition of pathological granules that appear in degenerative brain diseases.
|Manich G,del Valle J,Cabezón I,Camins A,Pallàs M,Pelegrí C,Vilaplana J||Age (Dordrecht, Netherlands) (36:151)||2014|
Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains.
AHB0042 was used in western blot to investigate the contribution of Ang II to Alzheimer disease.
|Tian M,Zhu D,Xie W,Shi J||FEBS letters (586:3737)||2012|
Ischemic preconditioning attenuates of ischemia-induced degradation of spectrin and tau: implications for ischemic tolerance.
AHB0042 was used in immunohistochemistry - paraffin section and western blot to elucidate the molecular mechanisms of ischemic tolerance
|Nakajima T,Ochi S,Oda C,Ishii M,Ogawa K||Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (32:229)||2011|
Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
AHB0042 was used in western blot to test if calpain cleave the cyclin-dependent kinase 5 activator p35 to a p25 fragment and results in tau hyperphosphorylation.
|Kerokoski P,Suuronen T,Salminen A,Soininen H,Pirttilä T||Biochemical and biophysical research communications (298:693)||2002|
|Not Applicable||Not Cited||
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.
AHB0042 was used in immunoprecipitation and western blot to investigate the effects of tau acetylation at Lys174
|Min SW,Chen X,Tracy TE,Li Y,Zhou Y,Wang C,Shirakawa K,Minami SS,Defensor E,Mok SA,Sohn PD,Schilling B,Cong X,Ellerby L,Gibson BW,Johnson J,Krogan N,Shamloo M,Gestwicki J,Masliah E,Verdin E,Gan L||Nature medicine (21:1154)||2015|
Tau reduction prevents disease in a mouse model of Dravet syndrome.
AHB0042 was used in immunohistochemistry to assess if tau reduction benefits intractable genetic epilepsies
|Gheyara AL,Ponnusamy R,Djukic B,Craft RJ,Ho K,Guo W,Finucane MM,Sanchez PE,Mucke L||Annals of neurology (76:443)||2014|
Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus.
AHB0042 was used in immunohistochemistry to examine the brains of 6-month-old rats treated neonatally with the glutamatergic beta-N-methylamino-L-alanine
|Karlsson O,Berg AL,Lindström AK,Hanrieder J,Arnerup G,Roman E,Bergquist J,Lindquist NG,Brittebo EB,Andersson M||Toxicological sciences : an official journal of the Society of Toxicology (130:391)||2012|
|Not Applicable||Not Cited||
Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease.
AHB0042 was used in immunohistochemistry to determine the distribution of tauopathy in different regions of the brain using the alpha-Syn overexpressing mouse model
|Kaul T,Credle J,Haggerty T,Oaks AW,Masliah E,Sidhu A||BMC neuroscience (12:null)||2011|
|Human||Not Cited||Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.||Forno LS,Langston JW,Herrick MK,Wilson JD,Murayama S||Acta neuropathologica (103:599)||2002|
|Not Applicable||Not Cited||
Expression of the HFE allelic variant H63D in SH-SY5Y cells affects tau phosphorylation at serine residues.
AHB0042 was used in ELISA to test if HFE polymorphisms are associated with alterations in tau phosphorylation in a human neuroblastoma cell line
|Hall EC,Lee SY,Mairuae N,Simmons Z,Connor JR||Neurobiology of aging (32:1409)||2011|
|Human||Not Cited||Development of an assay to screen for inhibitors of tau phosphorylation by cdk5.||Ahn JS,Musacchio A,Mapelli M,Ni J,Scinto L,Stein R,Kosik KS,Yeh LA||Journal of biomolecular screening (9:122)||2004|
|Expression of serine/threonine protein-kinases and related factors in normal monkey and human retinas: the mechanistic understanding of a CDK2 inhibitor induced retinal toxicity.||Saturno G,Pesenti M,Cavazzoli C,Rossi A,Giusti AM,Gierke B,Pawlak M,Venturi M||Toxicologic pathology (35:972)||2007|
||A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.||Zheng YL,Kesavapany S,Gravell M,Hamilton RS,Schubert M,Amin N,Albers W,Grant P,Pant HC||The EMBO journal (24:209)||2005|
|Human||Not Cited||Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration.||Bunker JM,Wilson L,Jordan MA,Feinstein SC||Molecular biology of the cell (15:2720)||2004|
G protein beta1/gamma2 subunit-interacting factor 1; MAPT; microtubule associated protein tau; Microtubule-associated protein tau; microtubule-associated protein tau, isoform 4; MTBT1; Neurofibrillary tangle protein; Paired helical filament-tau; PHF-tau; protein phosphatase 1, regulatory subunit 103; Tau microtubule-associated protein; Tau5
AI413597; AW045860; BOS_19251; DDPAC; FTDP-17; MAPT; MAPTL; MSTD; Mtapt; MTBT1; MTBT2; PPND; PPP1R103; pTau; RNPTAU; TAU